Return to top of page

Rally for Access

Published March 24, 2022

In June 2021, the Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s disease–the first new therapy Alzheimer’s therapy in almost 20 years. But in January 2022, the Centers for Medicare and Medicaid Services (CMS) announced it has no plans to cover the treatment for most seniors. Even worse, CMS’ decision will extend to future FDA approved Alzheimer’s treatments in this class of drugs. So on March 15, 2022, patients and advocates gathered to make sure their voices were heard. This video shares highlights from the rally.

Related Alzheimer’s Disease Videos

Watch video

Discussing Mental Health with Geriatric Neuropsychiatrist Dr. Dilip Jeste for This is Growing Old

May is Mental Health Awareness Month as well as Older Americans Month. This critical intersection implores us to explore emotional…

more.
Watch video

Preventing Atrial Fibrillation (AFib) Related Strokes

Atrial fibrillation (AFib) is one of the most common types of arrhythmias—or irregular heartbeats—and causes the heart to…

more.
Watch video

Living with Atrial Fibrillation (AFib)

Atrial fibrillation (AFib) is one of the most common types of arrhythmias—or irregular heartbeats—and causes the heart to…

more.